Management of patients with retroperitoneal tumors and a review of the literature

dc.contributor.authorGemici, Kazim
dc.contributor.authorBuldu, Ibrahim
dc.contributor.authorAcar, Turker
dc.contributor.authorAlptekin, Husnu
dc.contributor.authorKaynar, Mehmet
dc.contributor.authorTekinarslan, Erdem
dc.contributor.authorKaratag, Tuna
dc.date.accessioned2024-02-23T14:27:20Z
dc.date.available2024-02-23T14:27:20Z
dc.date.issued2015
dc.departmentNEÜen_US
dc.description.abstractBackground: Retroperitoneal tumors (RTs) develop insidiously and are generally seen as large masses, and 50% of RTs are larger than 20 cm at the time of diagnosis. In this article, we share our experience of 5 years of surgical management of RTs. Methods: We evaluated 28 RT cases operated on in three education hospitals in Turkey from January 2008 onwards, with regard to patients' demographic characteristics, complaints, weight loss figures, the location and size of the tumor, blood transfusion, intra-operational time, metastases (in malignant cases), additional organ resection, histological grade, local recurrences, average life expectancy, and post-operative treatment methods. Results: The mean age of the patients was 49 years (range, 18 to 78 years). Twenty (71.43%) were female, and 8 (28.57%) were male. The primary complaint was abdominal pain in 18 patients (64.28%). CT scans were performed in 17 (61%) patients, 10 (35.4%) underwent abdominal MR imaging, and 1 (3.6%) underwent both abdominal CT and abdominal MR imaging. A mass was palpated in the pelvis (suprapubic region) in seven (25%) of the patients during physical examination. The largest tumors were detected in the left lumbar area. The mean tumor size was 12.78 cm (range, 2 to 30 cm). The mean intra-operational time was 192 min (range, 70 to 380 min). The mean hospitalization period was 11 days (range, 8 to 23 days). Seven (25%) patients were reported to have benign tumors, while 21 (75%) were reported to have malignant tumors. The most frequently seen malignant pathology was liposarcoma (eight cases; 38.09%) followed by leiomyosarcoma (five cases; 23.8%) and malignant fibrous histiocytoma (four cases; 19.04%). The earliest local recurrence was detected in the 12th month and the latest in the 28th month. A total of 11 (52.3%) of the total of 21 malignant cases experienced local recurrence within 3 years. The 3-year average life expectancy was 85.7% in the 18 malignant cases. Conclusions: Due to the low response rate of all but two types of RT to chemotherapy, the best remaining treatment option is surgery with wide resection margins, whereby all macroscopic traces of tumor are removed.en_US
dc.identifier.doi10.1186/s12957-015-0548-z
dc.identifier.issn1477-7819
dc.identifier.pmid25881253en_US
dc.identifier.scopus2-s2.0-84928004185en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1186/s12957-015-0548-z
dc.identifier.urihttps://hdl.handle.net/20.500.12452/14547
dc.identifier.volume13en_US
dc.identifier.wosWOS:000353108100001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBmcen_US
dc.relation.ispartofWorld Journal Of Surgical Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectLiposarcomaen_US
dc.subjectRetroperitonealen_US
dc.subjectResectionen_US
dc.subjectMesenchymal Tumorsen_US
dc.titleManagement of patients with retroperitoneal tumors and a review of the literatureen_US
dc.typeReview Articleen_US

Dosyalar